NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2.13 Cr | ₹-7.78 Cr | ₹-1.67 Cr | ₹-22 Cr | ₹5.74 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-2.13 Cr |
| Mar2024 | ₹-7.78 Cr |
| Mar2023 | ₹-1.67 Cr |
| Mar2022 | ₹-22 Cr |
| Mar2013 | ₹5.74 Cr |
How is Cash Flow from Financing Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.13 Cr | Negative | |
| Mar2024 | ₹-7.78 Cr | Negative | |
| Mar2023 | ₹-1.67 Cr | Negative | |
| Mar2022 | ₹-22 Cr | Negative | |
| Mar2013 | ₹5.74 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹310.9 Cr | -0.7% | -1.7% | -19% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,446.1 Cr | -5.1% | 2.2% | -21.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,975.2 Cr | -2.1% | 2.9% | -11.3% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,053.8 Cr | -1.7% | -2.9% | 7.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹934.3 Cr | -1.6% | -4.3% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹555.3 Cr | 2.1% | 5.3% | 14.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -0.7% |
-1.7% |
-19% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses